Upregulation of endogenous prostaglandins to lower intraocular pressure
AssigneeAlcon Manufacturing, Ltd.
InventorsJon C. Nixon, Karen C. David
Life of this patent
Estimating the term…
Abstract
A method of lowering intraocular pressure (IOP) employs an upregulating agent that induces increased prostaglandin synthesis in the eye. The method of treatment entails administering to the eye of a mammal in need thereof a prostaglandin upregulating agent to increase endogenous prostaglandin synthesis and thereby effect a reduction in intraocular pressure. In a preferred embodiment the upregulating agent is IL-1.
Claims9
A method of treating glaucoma or elevated intraocular pressure in an eye of a human comprising topically administering to the eye a therapeutically effective amount of a non-prostanoid prostaglandin upregulating agent that induces endogenous prostaglandin synthesis in said eye to effect a reduction in intraocular pressure.
Dependencies are inferred from the claim text.